Filing Details
- Accession Number:
- 0001209191-19-047188
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-08-22 19:59:07
- Reporting Period:
- 2019-08-21
- Accepted Time:
- 2019-08-22 19:59:07
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326732 | Xencor Inc | XNCR | Pharmaceutical Preparations (2834) | 201622502 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1591306 | J John Kuch | C/O Xencor, Inc. 111 West Lemon Avenue Monrovia CA 91016 | Sr. Vice President & Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-08-21 | 20,000 | $11.05 | 113,629 | No | 4 | M | Direct | |
Common Stock | Disposition | 2019-08-21 | 40,000 | $41.27 | 73,629 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2019-08-21 | 20,000 | $0.00 | 20,000 | $11.05 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,065 | 2024-02-20 | No | 4 | M | Direct |
Footnotes
- Includes the following shares acquired by the Reporting Person pursuant to the Issuer's Employee Stock Purchase Plan: 544 shares of Common Stock acquired on December 10, 2018 and 603 shares of Common Stock acquired on June 10, 2019.
- The weighted average sale price for the transaction reported was $41.2681, and the range of prices were between $41.06 and $41.55. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- 25% of the shares subject to the option shall vest on the one year anniversary of February 21, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested and exercisable on the four year anniversary of the Vesting Commencement Date.